GS
Giriraj Shantilal
About Giriraj Shantilal
Data last updated:
Giriraj Shantilal is a Director at Ojal Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Ojal Pharmaceuticals Private Limited reported revenue of ₹26.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ojal Pharmaceuticals Private Limited U24290MP2019PTC047557 | Director | 18 Jan 2019 | 2019 | ₹26.1 Lakh (FY 2024) | Active |
Board colleagues of Giriraj Shantilal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Kumar Chopra | 08584645 | Ojal Pharmaceuticals Private Limited | Director |
| Kirti Shah | 10465941 | Ojal Pharmaceuticals Private Limited | Additional Director |
| Surbhi Gupta | 10465943 | Ojal Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Giriraj Shantilal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Giriraj Shantilal
Giriraj Shantilal currently holds 1 directorship: Ojal Pharmaceuticals Private Limited (Director, since 18 Jan 2019, revenue ₹26.1 Lakh (FY 2024)).
Giriraj Shantilal was first appointed on 18 Jan 2019 as Director at Ojal Pharmaceuticals Private Limited.
The current boards of Giriraj Shantilal's companies include Anil Kumar Chopra (Ojal Pharmaceuticals Private Limited), Kirti Shah (Ojal Pharmaceuticals Private Limited), Surbhi Gupta (Ojal Pharmaceuticals Private Limited).